Alessandra Serrao

Pubblicazioni

Titolo Pubblicato in Anno
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2024
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients INTERNAL AND EMERGENCY MEDICINE 2022
Thromboembolic events following mRNA vaccines for COVID 19: a case series JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2022
Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry 213S2 (2022) S11–S42 2022
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going? JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome HAEMOPHILIA 2021
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2020
Direct oral anticoagulants for the treatment of Mondor's disease not responding to low-molecular weight heparin PHLEBOLOGY 2020
Hemorrhagic Complications in Patients Treated With Azacitidine and Direct Oral Anticoagulants AMERICAN JOURNAL OF THERAPEUTICS 2020
PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2020
Outcomes of long‐term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2020
Effect of low or high doses of low‐molecular‐weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID‐19 BRITISH JOURNAL OF HAEMATOLOGY 2020
Direct Oral Anticoagulants In Patients With Hematologic Malignancies HEMATOLOGICAL ONCOLOGY 2020
post filter thromboembolic prophylaxis in vena cava filter carriers PHLEBOLOGY 2020
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms AMERICAN JOURNAL OF HEMATOLOGY 2020
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors CLINICAL DRUG INVESTIGATION 2020
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia THROMBOSIS RESEARCH 2020
The treatment of upper extremities deep vein thrombosis related to thoracic outlet syndrome with direct oral anticoagulants PHLEBOLOGY 2020
Role of Factor V R2 Haplotype and Common Thrombophilia Markers as Genetic Risk Factors for Ischemic Stroke JOURNAL OF STROKE MEDICINE 2020
Direct oral anticoagulants in patients affected by major congenital thrombophilia MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma